Susquehanna Fundamental Investments, LLC Cyclerion Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.58 - $1.15 $54,593 - $108,244	-94,126 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.96 - $1.78 $1,088 - $2,018	-1,134 Reduced 1.19%	94,126 $104,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.99 $11,118 - $21,309	-7,127 Reduced 6.96%	95,260 $164,000
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.13 $8,695 - $13,154	-3,185 Reduced 3.02%	102,387 $314,000
Q2 2021 Aug 11, 2021	BUY	$2.18 - $4.29 $230,146 - $452,903	105,572 New	105,572 $412,000

Q1 2021 May 17, 2021	SELL	$2.69 - $5.12 $40,371 - $76,840	-15,008 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.25 - $7.12 $6,525 - $20,648	-2,900 Reduced 16.19%	15,008 $46,000
Q3 2020 Nov 16, 2020	BUY	$3.46 - $8.39 $61,961 - $150,248	17,908 New	17,908 $109,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $101M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.